Member access

4-Traders Homepage  >  Shares  >  Amex  >  ImmunoCellular Therapeutics Ltd    IMUC   US4525361055

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Amex
10/14/2014 10/15/2014 10/16/2014 10/17/2014 10/20/2014 Date
0.715(c) 0.7008(c) 0.72(c) 0.7371(c) 0.7151(c) Last
212 869 290 340 857 114 281 177 310 454 Volume
+1.55% -1.99% +2.74% +2.38% -2.98% Change
More quotes
Company
ImmunoCellular Therapeutics Ltd. is a clinical-stage biotechnology company, which focuses on developing immune-based therapies for the treatment of brain and other cancers.Its cell-based vaccine technologies are primary platform technologies and commercial prospects will be heavily dependent on the... 
More about the company
Chart IMMUNOCELLULAR THERAPEUTIC
Duration : Period :
ImmunoCellular Therapeutic Technical Analysis Chart | IMUC | US4525361055 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 -
EBIT 2014 -11,2 M
Net income 2014 -12,5 M
Debt 2014 -
Yield 2014 -
Sales 2015 -
EBIT 2015 -17,3 M
Net income 2015 -17,2 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 0
Capi. / Sales 2015 0
Capitalization 43,4 M
More Financials
Latest news on IMMUNOCELLULAR THERAPEUTIC
10/03 IMMUNOCELLULAR THERAPEUTICS : to Present at Livingston Securities Conference on ..
10/03 IMMUNOCELLULAR THERAPEUTICS : Expands Cancer Immunotherapy Platform with Antigen..
09/26 IMMUNOCELLULAR THERAPEUTICS : to Present at Livingston Securities Conference on ..
09/24 IMMUNOCELLULAR THERAPEUTICS : Receives Positive Regulatory Feedback on ICT-107 S..
09/24 IMMUNOCELLULAR THERAPEUTICS : Expands Cancer Immunotherapy Platform with Antigen..
09/17 IMMUNOCELLULAR THERAPEUTICS : Other Events, Financial Statements and Exhibits (f..
09/17 IMMUNOCELLULAR THERAPEUTICS : Receives Positive Regulatory Feedback on ICT-107 S..
09/02 IMMUNOCELLULAR THERAPEUTICS : Change in Directors or Principal Officers (form 8-..
08/16 IMMUNOCELLULAR THERAPEUTICS : Reports 2Q Financial Results
08/12 IMMUNOCELLULAR THERAPEUTICS : Posts 2Q Financial Results
08/08 IMMUNOCELLULAR THERAPEUTICS : Management's Discussion and Analysis of Financial ..
08/07 IMMUNOCELLULAR THERAPEUTICS : Results of Operations and Financial Condition, Fin..
More news


Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF